If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Mounjaro ® (tirzepatide) injection
2.5 mg/5 mg/7.5 mg/10 mg/12.5 mg/15 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Can adults taking tirzepatide receive a COVID-19 vaccine?
The use of the COVID-19 vaccine in adults treated with tirzepatide has not been studied.
See important safety information, including boxed warning, in the attached prescribing information.
Use With COVID-19 Vaccines
Eli Lilly and Company (Lilly) has not studied the use of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in patients treated with tirzepatide.
Please speak with your healthcare provider about whether you should get a COVID-19 vaccine.
For additional questions regarding your treatment with tirzepatide and a COVID-19 vaccine, contact your health care provider. For current information and updates on a potential COVID-19 vaccine, please visit: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html.
SARS-CoV-2 is the virus that has caused the COVID-19 pandemic. Vaccines against SARS-CoV-2 are available.1
Enclosed Prescribing Information
Reference
1COVID-19 vaccines. World Health Organization (WHO). Accessed November 9, 2021. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines
Date of Last Review: May 25, 2022